Table 4.
The 10 most cited articles regarding the tumor microenvironment of pancreatic cancer.
| Title | Corresponding authors | Journal | Publication Year | Total Citations |
|---|---|---|---|---|
| Pancreatic cancer exosomes initiate premetastatic niche formation in the liver | Stanger, BZ | NATURE CELL BIOLOGY | 2015 | 1013 |
| Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma | Hingorani, SR | CANCER CELL | 2012 | 991 |
| CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans | Vonderheide, RH | SCIENCE | 2011 | 903 |
| The Pancreas Cancer Microenvironment | Tuveson, DA | CLINICAL CANCER RESEARCH | 2012 | 643 |
| Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303) | Kindler, HL | JOURNAL OF CLINICAL ONCOLOGY | 2010 | 577 |
| Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer | Tuveson, DA | GUT | 2013 | 499 |
| Tumor-Derived Granulocyte-Macrophage Colony-Stimulating Factor Regulates Myeloid Inflammation and T Cell Immunity in Pancreatic Cancer | Vonderheide, RH | CANCER CELL | 2012 | 485 |
| CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models | DeNardo, DG | CANCER RESEARCH | 2014 | 476 |
| Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS(+)/M1 Phenotype that Orchestrates Effective T Cell Immunotherapy | Huber, PE | CANCER CELL | 2013 | 449 |
| Stromal biology and therapy in pancreatic cancer | Tuveson, DA | GUT | 2011 | 445 |